AI assistant
Editas Medicine, Inc. — Director's Dealing 2016
Feb 2, 2016
33260_dirs_2016-02-02_bac8f017-016d-4c46-8eb8-cbef390790e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02
Reporting Person: Hack Andrew A. F. (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.23 | 2025-07-13 | Common Stock (173076) | Direct | |
| Stock Option (right to buy) | $6.48 | 2025-09-13 | Common Stock (84513) | Direct | |
| Stock Option (right to buy) | $11.21 | 2025-10-29 | Common Stock (9615) | Direct |
Footnotes
F1: This option was granted on July 14, 2015 and is scheduled to vest over four years with 25% of the shares scheduled to vest on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.
F2: This option was granted on September 14, 2015 and is scheduled to vest over four years with 25% of the shares scheduled to vest on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.
F3: This option was granted on October 30, 2015 and is scheduled to vest over four years with one quarter of the shares vesting on October 27, 2016, and the remaining shares vesting in equal monthly installments of 1/48th of the shares thereafter through October 27, 2019.